Detailed view for OVOC9879
Basic information
Onchocerca volvulus,
Source Database / ID: Wormbase Parasite
pI: 9.3372 |
Length (AA): 1505 |
MW (Da): 172483 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Network
Pfam domains
Gene Ontology
Metabolic Pathways
Structural information
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
| Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
|---|---|---|---|---|---|---|---|---|---|
| 12 | 66 | 3g8d (A) | 257 | 309 | 32.00 | 0.67 | 0.03 | 0.733181 | 0.79 |
Help me make sense of these data.
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Expression
Orthologs
Ortholog group members (OG5_217641)
| Species | Accession | Gene Product |
|---|---|---|
| Caenorhabditis elegans | CELE_T01B7.9 | Protein T01B7.9 |
| Onchocerca volvulus | OVOC9879 |
|
Essentiality
Phenotypes and Validation (curated)
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Annotated validation
Associated compounds / Druggability
Known modulators for this target
Predicted associations
By orthology with druggable targets
By sequence similarity to non orthologous druggable targets
| Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
|---|---|---|---|---|---|---|
| Staphylococcus aureus | Topoisomerase IV | 663 aa | 27.1% | 680 aa | Compounds | References |
| Staphylococcus aureus | DNA gyrase subunit B | 644 aa | 26.5% | 618 aa | Compounds | References |
| Mycobacterium smegmatis | DNA gyrase subunit B | 675 aa | 22.8% | 578 aa | Compounds | References |
| Staphylococcus aureus | DNA topoisomerase 4 subunit B | 663 aa | 27.1% | 680 aa | Compounds | References |
| Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) | DNA gyrase subunit B | 648 aa | 24.0% | 668 aa | Compounds | References |
| Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155) | DNA gyrase subunit B | 675 aa | 22.8% | 578 aa | Compounds | References |
| Staphylococcus aureus | DNA gyrase | 644 aa | 26.5% | 618 aa | Compounds | References |
| Staphylococcus aureus subsp. aureus Mu50 | DNA gyrase | 644 aa | 26.5% | 618 aa | Compounds | References |
| Streptococcus pneumoniae | ParE | 638 aa | 26.4% | 618 aa | Compounds | References |
Obtained from network model
Assayability
Assay information
Reagent availability
Bibliographic References